Industrial Automation Magazine India

Crosscope and KFBIO join hands to lead digital transformation for pathology in India and emerging markets

Published on : Monday 13-09-2021

The digitisation of the pathology workplace using scanners from KFBIO with the help of the pathologists to diagnose histopathology slides in a more efficient and accurate manner.

Mountain View, Calif., September 2021 – Crosscope, a leading AI software provider in digital pathology is collaborating with Ningbo Konfoong Bioinformation Tech Co Ltd (KFBIO), an innovative high-tech cutting edge whole slide imaging pathology scanner manufacturer. Through this collaboration, Crosscope will ensure the wide range and state-of-the-art Whole Slide Imaging Digital Pathology scanners are made available to the India market and ensure this cutting-edge technology is available for the pathology community to enable digital transformation in the pathology laboratories in India and emerging markets.

Today, Cancer is the dominant disease in India surpassing 1.39 million cases per year. Pathologists play a crucial role in the detection and diagnosis of a wide variety of cancers. The increasing number of cases has resulted in the increasing complexity of pathologists to diagnose the type of cancer. Today, the digitisation of clinical workflows is a key enabler for healthcare providers to ensure seamless and speedy diagnosis. By enabling transformation in histopathology, Crosscope aims to bring the advantages of digital tools and technology in an existing analog setting in the histopathology domain.

Crosscope team will ensure seamless availability of KFBIO Whole Slide Imaging scanners with an integrated approach towards delivering support, training and hand-holding to the healthcare providers in the region. "Pathology is on the cusp of digital transformation and Crosscope is very much dedicated to offer end-to-end digital pathology solutions to bridge gaps and usher in a new phase of personalized diagnostics. Crosscope is excited to team up with KFBIO to provide their scanners alongside our cutting-edge AI-software and collaboration platform to enable Oncopathology automation for our customers. Digitisation of pathology is a key area for the use of AI-based diagnostic algorithms to speed up and improve the diagnosis making an impact in reducing India's cancer burden," said Dr Jayendra Shinde, CEO Crosscope.